Using a neuromonitoring platform to improve care for traumatic brain injuries

by Tim Tedeschi,University of CincinnatiUC's neurocritical care team monitors metrics like blood flow, pressure, oxygen and glucose levels in the brain in real time and monitors trends and s

Updated on: January 10,2024

Using a neuromonitoring platform to improve care for traumatic brain injuries

by Tim Tedeschi,University of CincinnatiUC's neurocritical care team monitors metrics like blood flow, pressure, oxygen and glucose levels in the brain in real time and monitors trends and s

Updated on:January 10,2024

Study shows sense of smell is influenced by cues from other senses

by Stockholm UniversityCredit: Pixabay/CC0 Public DomainThe sense of smell is highly influenced by the cues from other senses, while the sense of sight and hearing are affected to a much lesser e

Updated on: April 06,2024

Study shows sense of smell is influenced by cues from other senses

by Stockholm UniversityCredit: Pixabay/CC0 Public DomainThe sense of smell is highly influenced by the cues from other senses, while the sense of sight and hearing are affected to a much lesser e

Updated on:April 06,2024

Over 7 million US seniors have mental declines that threaten financial skills

by Alan MozesAs Americans age, millions end up struggling with dementia or some level of memory impairment and diminished capacity to think clearly and make decisions.Yet a new study says that despite

Updated on: May 05,2024

Over 7 million US seniors have mental declines that threaten financial skills

by Alan MozesAs Americans age, millions end up struggling with dementia or some level of memory impairment and diminished capacity to think clearly and make decisions.Yet a new study says that despite

Updated on:May 05,2024

Gantenerumab does not slow clinical decline in early Alzheimer disease, research finds

by Elana GotkineThe use of gantenerumab leads to lower amyloid plaque burden at 116 weeks, but is not associated with slower clinical decline among patients with early Alzheimer disease, according to

Updated on: February 24,2024

Gantenerumab does not slow clinical decline in early Alzheimer disease, research finds

by Elana GotkineThe use of gantenerumab leads to lower amyloid plaque burden at 116 weeks, but is not associated with slower clinical decline among patients with early Alzheimer disease, according to

Updated on:February 24,2024

Noninvasive, ultrasound-based brain biopsy is feasible, safe in people: Study

by Tamara Bhandari,Washington University in St. LouisGraduate student Lu Xu wears a device designed by engineers, at Washington University in St. Louis, that targets ultrasound waves to precise

Updated on: January 07,2024

Noninvasive, ultrasound-based brain biopsy is feasible, safe in people: Study

by Tamara Bhandari,Washington University in St. LouisGraduate student Lu Xu wears a device designed by engineers, at Washington University in St. Louis, that targets ultrasound waves to precise

Updated on:January 07,2024

Multi-omics analysis identifies molecularly defined Alzheimer's disease subtypes

by Jacqueline Mitchell,Beth Israel Deaconess Medical CenterStudy design. Credit:PLOS Biology(2024). DOI: 10.1371/journal.pbio.3002607Omics analysis is the process of analyzing large

Updated on: June 15,2024

Multi-omics analysis identifies molecularly defined Alzheimer's disease subtypes

by Jacqueline Mitchell,Beth Israel Deaconess Medical CenterStudy design. Credit:PLOS Biology(2024). DOI: 10.1371/journal.pbio.3002607Omics analysis is the process of analyzing large

Updated on:June 15,2024

Repetitive negative thinking linked to dementia risk

by University College LondonCredit: Pixabay/CC0 Public DomainPersistently engaging in negative thinking patterns may raise the risk of Alzheimer's disease, finds a new UCL-led study.In the st

Updated on: June 01,2024

Repetitive negative thinking linked to dementia risk

by University College LondonCredit: Pixabay/CC0 Public DomainPersistently engaging in negative thinking patterns may raise the risk of Alzheimer's disease, finds a new UCL-led study.In the st

Updated on:June 01,2024

Researchers identify path to prevent cognitive decline after radiation

by Kelsie Smith Hayduk,University of Rochester Medical CenterCredit: Pixabay/CC0 Public DomainResearchers at the Del Monte Institute for Neuroscience at the University of Rochester find that mic

Updated on: January 09,2024

Researchers identify path to prevent cognitive decline after radiation

by Kelsie Smith Hayduk,University of Rochester Medical CenterCredit: Pixabay/CC0 Public DomainResearchers at the Del Monte Institute for Neuroscience at the University of Rochester find that mic

Updated on:January 09,2024

Psychological well-being at 52 years could impact on cognitive functioning at 69 years

by IOS PressCredit: CC0 Public DomainPeople around the world are living longer, and dementia has consequently become recognized as a public health priority in many countries. The Lancet Commissio

Updated on: March 24,2024

Psychological well-being at 52 years could impact on cognitive functioning at 69 years

by IOS PressCredit: CC0 Public DomainPeople around the world are living longer, and dementia has consequently become recognized as a public health priority in many countries. The Lancet Commissio

Updated on:March 24,2024

Faster, stronger … smarter? New research shows the importance of brain training for junior athletes

by Kylie A Steel, Clare MacMahon and Todd Pickering,The ConversationCredit: CC0 Public Domain"Look for the gap!" "Move into space!" "Who's free?"Sound familiar?

Updated on: July 31,2024

Faster, stronger … smarter? New research shows the importance of brain training for junior athletes

by Kylie A Steel, Clare MacMahon and Todd Pickering,The ConversationCredit: CC0 Public Domain"Look for the gap!" "Move into space!" "Who's free?"Sound familiar?

Updated on:July 31,2024

New memory drug moves into Phase 1 clinical study

by National Institutes of HealthAn experimental drug that may improve memory is now being tested in a Phase 1 safety trial. The compound, BPN14770, was developed by Tetra Discovery Partners, with

Updated on: February 27,2024

New memory drug moves into Phase 1 clinical study

by National Institutes of HealthAn experimental drug that may improve memory is now being tested in a Phase 1 safety trial. The compound, BPN14770, was developed by Tetra Discovery Partners, with

Updated on:February 27,2024

Are stressed-out brain cells the root cause of neurodegenerative disease?

byUniversity of California - BerkeleyAn illustration of a brain cell in a person with Alzheimer's disease, showing the accumulation and clumping of tau proteins (blue squiggles) in the cytop

Updated on: April 09,2024

Are stressed-out brain cells the root cause of neurodegenerative disease?

byUniversity of California - BerkeleyAn illustration of a brain cell in a person with Alzheimer's disease, showing the accumulation and clumping of tau proteins (blue squiggles) in the cytop

Updated on:April 09,2024